Christine CHEVREAU, MD
Institut Universitaire du Cancer Toulouse Oncopole · IUCT-O · Institut Claudius Regaud
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Christine CHEVREAU, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:43 UTC. Open this list on ClinicalTrials.gov
- N/ANCT03263416 · Study Evaluating Treatment Adherence in Patients Treated With Oral Targeted Therapy in Oncology Supported by a Dedicated and Coordinated Follow-up Compared to Standard Follow-up.Institut Claudius Regaud · completed · Metastatic Solid Tumor · principal investigator
- Ph4NCT02555748 · Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell CarcinomaInstitut Claudius Regaud · completed · Metastatic Renal Cell Cancer · principal investigator
- Ph2NCT00864318 · Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad PrognosisInstitut Claudius Regaud · completed · Germ Cell Tumors · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:43 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.